1. The enzyme fraction obtained from the pH 5 enzyme of non-lactating bovine mammary gland between 40 and 100% ammonium sulphate saturation markedly inhibited the AMP-incorporating activity of rat liver nucleotide-incorporating enzyme. This inhibitory effect has been attributed to high nuclease activity which can be partially removed by adsorption of the enzyme fraction on to calcium phosphate gel. 2. The degradation action ofthe calcium phosphate-purified enzyme is confined mainly to the terminal trinucleotide sequence -pCpCpA of tRNA, its effect being analogous to that of venom phosphodiesterase. This enzyme is heat labile and very readily loses its degradative activity. 3. Treatment of the enzyme fraction with Macaloid results in complete removal of the phosphodiesterase, leaving an enzyme capable of incorporating AMP into tRNA. 4. Transfer RNA extracted from non-lactating bovine mammary gland in the presence of polyvinyl sulphate and Macaloid is able to accept amino acids with an efficiency 30% of that shown by lactating bovine mammary-gland tRNA isolated under identical conditions.
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Reports from numerous laboratories have demonstrated the enzymic synthesis of aminoacyl-tRNA derivatives (Hoagland, Stephenson, Scott, Hecht & Zamecnik, 1958; Schweet, Bovard, Allen & Glassman, 1958; Weiss, Acs & Lipmann, 1959 ) the amino acid of which is linked to either the 2'-or the 3'-hydroxyl group of the terminal nucleotide residue in tRNA. The terminal nucleotide has been conclusively identified as adenylic acid Zachau, Acs & Lipmann, 1958) , which in turn is adjacent to a dinucleotide sequence of two cytidylic acid residues (Hecht, Stephenson & Zamecnik, 1959) . If one or more of the terminal nucleotides is removed, the tRNA loses its ability to accept amino acids or to bind to ribosomes (Cannon, Krug & Gilbert, 1963) , two processes that are essential for protein synthesis.
The enzyme responsible for the incorporation of the terminal adenylate and cytidylate residues into tRNA isolated from a 'preincubated pH 5 fraction' of rat liver was partially purified by Herbert (1959) and Canellakis & Herbert (1960) . Preiss, Dieckmann & Berg (1961) and Furth, Hurwitz, Krug & Alexander (1961) have also isolated a similar enzyme from E8cherichia coli. The enzyme was further purified by Daniel & Littauer (1963) who reported that it was able to incorporate not only adenine and cytosine nucleotides, but also uridine into the terminal positions of tRNA. This enzyme appears to catalyse the reaction with any tRNA regardless of its amino acid specificity or of its source.
Studies on non-lactating bovine mammarygland tRNA have indicated that the molecule when isolated in the absence of ribonuclease inhibitors is unable to accept amino acids due to the lack of the terminal adenine nucleotide and possibly the terminal -pCpCpA nucleotide sequence (Herrington & Hawtrey, 1970) . Once these nucleotides have been replaced by utilizing the rat liver nucleotideincorporating enzyme in the presence of ATP and CTP, the molecule is able to both accept amino acids and transfer these amino acids to the growing polypeptide chain present on the ribosomes. It is the purpose of this paper to present evidence that the major portion of bovine tRNA, in fact, lacks the terminal trinucleotide sequence -pCpCpA, possibly owing to the action of a nuclease enzyme that is present in the cytoplasm of the mammarygland cells. A method is also given for the purification of the nucleotide-incorporating enzyme from the pH 5 fraction of non-lactating bovine mammary gland. Scintillation chemicals. The scintillation fluid contained 0.5% 2,5-diphenyloxazole (PPO) and 0.03% 1,4-bis-(5-phenyloxazol-2-yl)benzene (POPOP) (both purchased from Packard Instrument Co. Inc., La Grange, IIl., U.S.A.) in chromatography-grade toluene.
Preparation of subcellular fractions. Homogenates of rat liver and non-lactating bovine mammary gland were prepared in medium A, containing (final concentrations): 0.25M-sucrose, 5mM-MgCl2, 25mM-KCl and 50mM-tris-HCI buffer, pH7.6, as described by Hawtrey, Schirren & rijkstra (1963) and Herrington & Hawtrey (1969a) respectively.
(1) pH5 enzyme fractions. These were prepared from the cell sap of rat liver and non-lactating bovine mam. mary gland as described by Hawtrey et al. (1963) . The fractions were suspended in medium A, assayed for protein concentration and stored at -15°C until required.
(2) Deacylated tRNA. tRNA was isolated from the pH5 enzyme fractions and then deacylated as described by Herrington & Hawtrey (1969b) .
(3) Twice-pyrophosphorolysed rat liver tRNA. This was prepared from the pH5 enzyme fraction of rat liver according to the procedure of Daniel & Littauer (1963) . The sample of RNA was stored at -150C and thawed just before use.
(4) Aminoacyl-tRNA synthetases. These were prepared from the rat liver pH5 enzyme according to the method of Hele (1961) as modified by Herrington & Hawtrey (1970) . (5 (Keilin & Hartree, 1938) . In this method the fraction obtained at 100% (NH4)2SO4 saturation was dissolved in 10mm-tris-HCI buffer, pH7.6 and dialysed against the same buffer until free of sulphate. A suspension of Ca3(PO4)2 gel was added to the enzyme solution in the proportion of 3.4mg dry wt. of gel/15mg of enzyme protein. After standing for 15min at 40C, the gel was removed by centrifugation at 2000g for 10min and to the supernatant was added additional gel (10.2mg of gel/15mg of enzyme protein) sufficient to adsorb 80-100% of the enzyme. The suspension was thoroughly stirred, allowed to stand for 15min at 40C and then centrifuged. The supernatant was discarded and the gel washed twice with 3ml of 10mM-potassium phosphate buffer, pH7.6. The enzyme was finally eluted with 3ml of 50mM-potassium phosphate buffer, pH 7.6. The process was repeated to ensure complete removal of the enzyme from the gel. (c) Stage 3 purification. In an attempt to remove contaminating nucleases the calcium phosphate gel-purified enzyme was treated with Macaloid in the proportion of 30mg of Macaloid/mi of enzyme solution. After stirring gently for 15min at 40C, the Macaloid was removed by low-speed centrifugation.
At all stages of purification, experiments were conducted on the enzyme fractions by testing for nucleotideincorporating activity and nuclease activity.
Preparation of radioactively labelled bovine tRNA. 14C-labelled cytosine and 3H-labelled adenine nucleotides were added to the terminal end of normal deacylated bovine mammary-gland tRNA as follows. The incubation medium contained rat liver nucleotide-incorporating enzyme (1 mg of protein), 5mM-phosphoenolpyruvate, 100,ug of pyruvate kinase, 0.15M-sucrose, 31 mM-tris-HCI buffer, pH7.6, 16mM-KCI, 6mM-MgCI2, 5mg of deacylated bovine tRNA, 3H-labelled ATP (60uCi) and 14C-labelled CTP (10,uCi) in a total volume of 22ml.
Incubation was at 370C for 30min. At the end of the incubation the sample was mixed with an equal volume of 90% (w/v) phenol and shaken at room temperature for 90min. The emulsion was broken by centrifugation at 1400g for 30min and the RNA was precipitated from the aqueous phase at -15°C by the addition of 0.1 volume of 20% (w/v) potassium acetate and 2.5 volumes of 96% (v/v) Gornall, Bardawill & David (1949) with bovine serum albumin as standard. The concentration of RNA was measured spectrophotometrically at 260nm (El°170) (Hawtrey, Nourse & King, 1966) .
RESULTS
Characterization of bovine nucleotide-incorporating enzyme fractions at different stages of purification.
The nucleotide-incorporating enzyme was prepared from non-lactating bovine mammary gland in three different stages, each stage increasing in the degree of purification. Each fraction was then tested for its ability to incorporate AMP terminally into either twice-pyrophosphorolysed rat liver RNA or normal deacylated bovine tRNA and also its tendency to degrade tRNA.
(1) Stage 1 purification. The results presented in Table 1 show that the enzyme fraction prepared from non-lactating bovine mammary gland up to stage 1 purification is totally incapable of incorporating AMP into the 3'-terminus position of twice-pyrophosphorolysed rat liver tRNA. This inability is presumably due to the high nuclease activity of the fraction which results in approx. 71.6% degradation of the tRNA molecule.
(2) Stage 2 purification. In an attempt to determine whether non-lactating bovine mammary gland contains an enzyme capable of incorporating AMP and CMP into tRNA, further fractionation was adopted in the hope of removing contaminating nucleases. Adsorption of the bovine mammarygland enzyme fraction on to calcium phosphate gel and elution with 50 mM-potassium phosphate buffer, pH 7.6, resulted in a marked decrease in nuclease activity from approx. 70% degradation of deacylated rat liver tRNA to between 10 and 15%. Nevertheless, the results presented in Table, 1 show that this enzyme fraction is still incapable of incorporating AMP on to tRNA. In addition, the decrease in nuclease activity is insufficient to prevent the inhibition exerted by the bovine mammary-gland enzyme on the ability of the rat liver enzyme to incorporate the nucleotides into tRNA components lacking the terminal -pCpCpA sequence. Treatment of the bovine mammarygland enzyme fraction at 1050C for lOmin before incubation in the presence of the rat liver enzyme resulted in almost total loss of nuclease activity with a concomitant increase in AMP incorporation.
When twice-pyrophosphorolysed rat liver tRNA was incubated with 3H-labelled ATP and the nucleotide-incorporating enzyme from rat liver in the presence of increasing concentrations of the bovine mammary-gland enzyme fraction (stage 2 purification), the results shown in Fig. 1 As shown in Table 2 , treatment of the radioactively labelled bovine tRNApCpCpA with 10mM-inorganic pyrophosphate and the rat liver nucleotideincorporating enzyme results in the complete removal of the terminal adenine nucleotide but not the cytosine nucleotides. When the same RNA component, however, is treated with the corresponding bovine mammary-gland enzyme fraction, the terminal AMP is removed as well as most of the CMP (approx. 67%). The presence of the rat liver enzyme has no effect on preventing the terminal degradation by the bovine mammary-gland enzyme.
Bovine tRNA. In a previous paper (Herrington & Hawtrey, 1970) it was shown that tRNA isolated from non-lactating bovine mammary gland by phenol-sodium dodecyl sulphate extraction is unable to accept amino acids due to the absence of the terminal trinucleotide sequence. The results presented in Table 3 , however, illustrate that tRNA isolated from lactating bovine mammary gland is quite capable of accepting amino acids to a degree more efficient than that of deacylated rat liver Table 2 . Liberation of adenine and cyto8ine ribonucleotides into the acid-8oluble fraction by treatment of bovine tRNApCpCpA with different nucleotide-incorporating enzymes
The incubation medium contained 200,ug of radioactively labelled bovine tRNApCpCpA (see the Materials and Methods section for preparation), 0.15 M-sucrose, 30mM-tris-HCI buffer, pH 7.6, 15mM-KCI, 7.5mM-MgCl2, 13mm-potassium phosphate buffer, pH7.6, and the indicated nucleotide-incorporating enzyme fraction (stage 2 purification) in a total volume of 1.2ml. All incubations were carried out in duplicate at 370C for 30min.
Radioactive tRNA. It is apparent, therefore, that tRNA isolated under the defined conditions from nonlactating bovine mammary gland, lacks the terminal trinucleotide -pCpCpA sequence, whereas in lactating mammary gland this sequence is intact.
If, however, tRNA is isolated from non-lactating bovine mammary gland in the presence of polyvinylsulphate and Macaloid (both of which inhibit ribonuclease activity), it is capable of accepting some amino acids with approx. 30% efficiency.
Nonetheless the major portion of tRNA still appears to lack the -pCpCpA trinucleotide sequence and as such is incapable of accepting amino acid.
DISCUSSION
Attempts to demonstrate the incorporation of amino acids into protein by subcellular fractions derived from non-lactating bovine mammary gland have met with little success (Herrington & Hawtrey, 1969a) . This failure has been attributed to the presence of active nucleases in the cytoplasm and to tRNA, which appears to be unable to accept amino acids due to the absence of the terminal trinucleotide sequence -pCpCpA (Herrington & Hawtrey, 1970) .
Considerable work has been carried out on the enzymes that catalyse the reaction for the incorporation of ribonucleotides into the terminal position of tRNA (Preiss et al. 1961; August, Ortiz & Hurwitz, 1962; Daniel & Littauer, 1963) . Initial attempts to isolate a similar enzyme from nonlactating bovine mammary gland met with little success since the possible presence of such an enzyme would be masked by active nucleases which would consequently remove the terminal -pCpCpA sequence as soon as it had been incorporated. Treatment of the enzyme fraction with calcium phosphate gel considerably decreased the RNA degradative activity, although a very small percentage remained which would nevertheless still be capable of inhibiting AMP incorporation into tRNA.
It appears that one or more of the nuclease enzymes present in the nucleotide-incorporating enzyme fraction (stage 1 purification) from nonlactating bovine mammary gland is capable of removing nucleotides from the 3'-terminal end of tRNA. Experimental evidence suggests that only the terminal -pCpCpA grouping is removed (Table 2) .
Cannon (1966) reported that during exponential growth of E. coli the terminal adenosine of tRNA is unstable and exhibits a very slow turnover. This turnover phenomenon has been implicated with the action of an enzyme, ribonuclease II. A possible explanation for the adenosine turnover was originally put forward by Rosset & Monier (1963) who proposed that tRNA molecules, charged with amino acids could be resistant to exonucleolytic attack from the 3'-end, but once the amino acids had been removed they became susceptible. Hence in mammary-gland tissue that is no longer synthesizing milk protein, the RNA will become more susceptible to nuclease attack resulting in the removal of the terminal -pCpCpA sequence. During milk production, however, where there is a rapid exchange of amino acids from tRNA into protein the damage could be repaired quickly by a highly functional nucleotide-incorporating enzyme system, since Bucovaz & Davis (1961) have shown that lactating mammary gland readily forms aminoacyltRNA. This is substantiated by the results presented in Table 3 in which tRNA isolated from lactating mammary gland is readily able to accept amino acids to form aminoacyl-tRNA complexes. The results reported in the present paper suggest that the nuclease activity exhibited by the calcium phosphate gel-purified enzyme (stage 2 purification) is similar to that of phosphodiesterase or ribonuclease II present in E. coli since, when reacted with tRNA it completely removes the terminal adenylate residue and almost all of the cytidylate units (see Table 2 ).
Definite proof, however, is given for the existence ofan active and functional nucleotide-incorporating enzyme in non-lactating bovine mammary gland but its effect appears to be completely masked by the presence of phosphodiesterases. However, once the contaminating nucleases have been removed by treatment of the enzyme fraction with Macaloid, the remaining enzymes are able to terminally incorporate AMP into tRNA.
When tRNA is isolated from non-lactating bovine mammary gland in the presence of polyvinyl sulphate and Macaloid, approx. 30% of the total tRNA is able to accept amino acids. This suggests, contrary to previous assumptions, that at least a proportion of the tRNA molecules contain intact terminal trinucleotide sequences at the 3'-end (Herrington & Hawtrey, 1970) . tRNA from lactating mammary gland, however, is able to accept amino acids, even more efficiently than deacylated rat liver tRNA.
From the evidence presented it appears that the nucleases in non-lactating bovine mammary gland mask the effect of the nucleotide-incorporating enzymes, thereby playing an important role in the control of synthesis, since the biological activity of tRNA with respect to amino acid acceptance and binding to ribosomes is critically dependent upon the integrity of its terminal nucleotide sequence. One may therefore suggest that the initiation of lactation results in a decrease in nuclease activity followed by an increase in activity of the nucleotideincorporating enzyme, with the consequent formation of RNA components containing the terminal nucleotide sequence -pCpCpA. These molecules would once again be capable of forming aminoacyltRNA complexes, thereby allowing milk protein synthesis to proceed normally.
